Haleon broker forecast
WebMar 2, 2024 · Haleon, the world's biggest standalone consumer health business with brands such as Sensodyne toothpaste and Advil painkillers, on Thursday forecast 4-6% organic …
Haleon broker forecast
Did you know?
WebJul 18, 2024 · Haleon has a world-class portfolio of brands including Advil, Centrum, Sensodyne, Robitussin, and TUMS and will continue to develop category leading brands that address real consumer health needs ... WebJul 29, 2024 · It is tweaking higher by both its earnings per share and earnings before tax estimates in wake of the update. It retains its ‘hold’ recommendation on Haleon, which it reckons is worth a 340p share, up from 330p. Down 7% since listing in London and New York, the stock is currently changing hands for 287p each.
WebApr 14, 2024 · The consensus estimate for Haleon’s current full-year earnings is $0.42 per share. Jefferies Financial Group also issued estimates for Haleon’s FY2024 earnings at $0.46 EPS, FY2025 earnings at ... WebJul 19, 2024 · Pfizer ( PFE) got a stake of 32% in Haleon. GSK retained a stake of 13.5% in the business. Haleon also paid a special dividend of £7 billion to GSK shareholders. Haleon generated about £10 billion in revenue in 2024. It expects revenue growth in the range of 4% to 6% annually in the coming years.
WebHaleon PLC quote is equal to 319.450 GBX at 2024-03-09. Based on our forecasts, a long-term increase is expected, the "HLN" stock price prognosis for 2028-03-03 is 1008.578 GBX. With a 5-year investment, the revenue is expected to be around +215.72%. Your current $100 investment may be up to $315.72 in 2028. WebJul 19, 2024 · Haleon, the newly-created consumer healthcare business that was spun out of pharmaceutical giant GSK last month, saw its share price plunge by nearly 12%, while …
WebJan 20, 2024 · As of September 30, 2024, Haleon Plc reported cash worth GBP1.09 billion together with short term borrowings of GBP684 million, in addition to long term borrowings of GBP11.353 billion. Besides ...
WebNov 16, 2024 · Haleon, the former consumer health arm of Glaxo Smith Kline, last week reported a 16.1% increase in 3Q revenue, and upped its revenue forecast a second time since splitting from GSK earlier this year. Reflecting ‘positive momentum’, Haleon is now expecting FY22 organic revenue growth of 8.0-8.5% for next year. insular apartments norderneyWebJun 18, 2024 · Barclays reckons Haleon shares, once listed on July 18, could be worth anywhere from 249p to 416p, which adds up to an equity valuation of £23bn-£38bn. This is based on valuations ‘multiples’ ranging from 15 to 25 times earnings. insular areas and femaWebAug 2, 2024 · That would be good news for Haleon, whose portfolio includes several popular cold and flu medicines. However, although I expect Haleon’s cash generation to … insular areas doiWebJun 2, 2024 · Summary. At a £50 billion IPO, Haleon could trade at a Market Cap/EBIT of 19x if we annualized GSK's Q1 results. Haleon is expected to grow net sales between 4-6% according to management. Haleon ... job is credit car dealershipWebApr 12, 2024 · HLN Stock Forecast, Price & News (Haleon) NYSE:HLN Haleon - HLN Stock Forecast, Price & News $8.97 +0.34 (+3.94%) (As of 04/6/2024 05:11 PM ET) … job is a righteous manWeb2 days ago · Stock Price Forecast. According to 25 stock analysts, the average 12-month stock price forecast for Haleon stock is $ 8.77 , which predicts a decrease of -2.23%. The lowest target is $ 6.4 and the highest is $ 10.64. On average, analysts rate Haleon stock as … jobis backpack leatherWebSep 5, 2024 · Haleon plc ( NYSE: HLN) has a range of brands that command serious share in their consumer healthcare markets, with special positioning in some of the higher growth categories. The company guides... jobis clothes